N. Garlie

Flow cytometry assessment of residual melanoma cells in tumor‐infiltrating lymphocyte cultures

J. Richards, M. Oaks, J. Treisman, 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumors.

L. Lum, D. V. Van Epps, N. Garlie, 2001, Journal of hematotherapy & stem cell research.

T cells coactivated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancer.

B. Levine, C. June, L. Lum, 1999, Journal of immunotherapy.

Immune Modulation in Cancer Patients After Adoptive Transfer of Anti-CD3/Anti-CD28–Costimulated T Cells—Phase I Clinical Trial

L. Lum, J. Treisman, N. Garlie, 2001, Journal of immunotherapy.

Idiotype-specific autologous T-cell interactions restricted by HLA-DR.

D. Eckels, N. Garlie, 1994, Human immunology.

T cells activated in vitro as immunotherapy for renal cell carcinoma: characterization of 2 effector T-cell populations.

N. Garlie, A. Lefever, R. Siebenlist, 2001, The Journal of urology.

Systemic therapy for cutaneous melanoma.

J. Treisman, N. Garlie, 2010, Clinics in plastic surgery.

Immune Modulation in Cancer Patients After Adoptive Transfer of Anti-CD3/Anti-CD28-Costimulated T Cells-Phase I Clinical Trial.

L. Lum, J. Treisman, N. Garlie, 2001, Journal of immunotherapy : official journal of the Society for Biological Therapy.